Serotonergic psychedelics and 3,4-methylendioxtmethamphetamine (MDMA) are promising treatments for mental disorders with a continuously evolving evidence base. We searched Pubmed/Scopus/clinical trial registries up to 08july2025 for double-blind randomized controlled trials (RCTs) testing MDMA or serotonergic psychedelics in patients with mental disorders. Primary outcomes were change in...
In recognition of the increasing scholarly and clinical attention to this concept, Frontiers in Psychology established a Mindfulness section in 2022. In this article, we briefly review the conceptualization of mindfulness and its , discuss its different facets, done in the context of the section's third anniversary. Furthermore, we , and discuss how mindfulness, both as a disposition and the...
Metabolic EngineeringNovember 5, 2025Cui Guo, Nguyen N T Luu, Maryem M Adwer et al.5 citations
Psychedelic-assisted therapy is emerging as a highly promising approach for treating depression, with psilocybin, a psychoactive compound in magic mushrooms, gaining the most recognition for its efficacy in treating post-traumatic stress disorder and treatment-resistant depression. However, its low natural abundance makes extraction costly, necessitating alternative production methods. While...
Abstract This chapter presents a case of a man in his 70s who, despite being generally healthy, enters a dissociative state triggered by a fraudulent computer message and a commanding voice. He follows instructions to withdraw $27,000 and deposit it in a Bitcoin machine, while his wife observes his trance-like compliance despite her protests. The chapter explores dissociation as a...
Although psychedelics have shown therapeutic potential in treating conditions such as depression, PTSD, and addiction, concerns remain regarding ethical practices, participant diversity, and the structural limitations of prevailing theoretical frameworks. This theoretical framework critically examines the dominant biopsychic model that underpins much of contemporary psychedelic research and...
After many years of stigma and neglect, there is a resurgence of interest in the therapeutic use of psychedelic drugs. Anecdotal and evidence-based reports indicate psychedelics as a possible treatment for depression, anxiety, PTSD, substance abuse, and other disorders resistant to conventional medical interventions. The available data, however, are limited and the use of psychedelic substances...
El Trastorno de Estrés Postraumático (TEPT) constituye un desafío clínico significativo debido a las altas tasas de resistencia a la farmacoterapia convencional y el abandono de las terapias tradicionales. Ante este escenario, el actual "renacimiento psicodélico" propone el uso controlado de sustancias psicoactivas como herramientas para potenciar el procesamiento del trauma. El objetivo de...
Background Psilocybin-assisted psychotherapy (PAP) has gained attention as a promising intervention for conditions including depression, anxiety and post-traumatic stress disorder, but understanding of its side-effects is limited. This review evaluates the quality of side-effects reporting in PAP trials, to guide treatment, policy and research. Aims To assess side-effects reporting quality in...
Psychedelics, including psilocybin, lysergic acid diethylamide, and dimethyltryptamine, and entactogens such as 3,4-methylenedioxymethamphetamine are being investigated for treatment-resistant depression, post-traumatic stress disorder, anxiety, and substance use disorders. These compounds act primarily through serotonin 5-HT2A receptor agonism (psychedelics) or monoamine release (MDMA),...
Background. The water soluble form of quercetin, corvitin, may potentially be useful for preventing complications of short-term ketamine analgesia in children and adults, as well as preventing myocardial damage in the treatment of depression and post- traumatic stress disorder. Purpose – was to determine the effect of quercetin on the myocardium of rats under conditions of ketamine-induced...